Coexpression of Interleukin-12 Chains by a Self-Splicing Vector Increases the Protective Cellular Immune Response of DNA andMycobacterium bovisBCG Vaccines againstMycobacterium tuberculosis
- 1 April 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (4) , 1949-56
- https://doi.org/10.1128/iai.70.4.1949-1956.2002
Abstract
More effective vaccines againstMycobacterium tuberculosismay contribute to the control of this major human pathogen. DNA vaccines encoding single mycobacterial proteins stimulate antimycobacterial T-cell responses and induce partial protection againstM. tuberculosisin animal models. The protective efficacy of these vaccines encoding a single antigen, however, has been less than that afforded by the current vaccine,Mycobacterium bovisbacillus Calmette-Guérin (BCG). The heterodimeric cytokine interleukin-12 (IL-12) potentiates the induction and maintenance of the type 1 helper T-cell response. We have developed a novel self-splicing vector based on the 2A protein of foot-and-mouth disease virus that permits the coordinate expression of both chains of IL-12 (p2AIL12). Coimmunization with this vector and DNA expressingM. tuberculosisantigen 85B or MPT64 enhanced the specific lymphocyte proliferative response and increased the frequency of specific gamma interferon-secreting T cells against the whole protein and a defined CD8+T-cell epitope on MPT64. Further, coimmunizing with p2AIL12 significantly increased the protective efficacy of DNA-85 in the lung against an aerosol challenge withM. tuberculosisto the level achieved with BCG. Therefore, codelivery of an IL-12-secreting plasmid may be a potent strategy for enhancing the protective efficacy of vaccines againstM. tuberculosis.Keywords
This publication has 47 references indexed in Scilit:
- Priming by DNA Immunization Augments Protective Efficacy ofMycobacterium bovisBacille Calmette-Guerin against TuberculosisInfection and Immunity, 2001
- Stimulation of Dendritic Cells via CD40 Enhances Immune Responses toMycobacterium tuberculosisInfectionInfection and Immunity, 2001
- Enhanced Immunogenicity of CD4+T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine TuberculosisInfection and Immunity, 2001
- CD4+and CD8+T Cells Mediate Adoptive Immunity to Aerosol Infection ofMycobacterium bovisBacillus Calmette‐GuérinThe Journal of Infectious Diseases, 2000
- Production of Interleukin-12 as a Self-Processing 2A PolypeptideJournal of Interferon & Cytokine Research, 1999
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient PatientsScience, 1998
- T Cell Response to Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1993
- Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammationProgress in Growth Factor Research, 1992
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989